Nancy Becker, DO
Otolaryngology · Enumclaw, WANPI 1679582654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AstraZeneca at 24.4% of the total. 2025 is the largest year on record at $1,849, 7.4 times the $251 reported in 2019. Among otolaryngology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 190 payments — averaging $29.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$618
- Aerin Medical Inc.$515
- Revance Therapeutics, Inc.$473
- Merz North America, Inc.$348
- Sanofi$319
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,568100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $1,359 |
| GSK | 27 | $618 |
| Aerin Medical Inc. | 4 | $515 |
| Revance Therapeutics, Inc. | 11 | $473 |
| Merz North America, Inc. | 6 | $348 |
| Sanofi | 13 | $319 |
| Regeneron Healthcare Solutions, Inc. | 13 | $293 |
| Kaleo, Inc. | 11 | $287 |
| AbbVie(2 entities) | 7 | $257 |
| Phathom Pharmaceuticals, Inc. | 6 | $224 |
| Optinose US, Inc. | 6 | $109 |
| Novartis | 4 | $96 |
| Galderma Laboratories, L.p. | 4 | $73 |
| Biohaven Pharmaceuticals, Inc. | 3 | $64 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Mimedx Group, Inc. | 2 | $41 |
| Smith+Nephew | 2 | $40 |
| 3b Medical, Inc. | 3 | $36 |
| Alk-abello, Inc | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Fisher & Paykel Healthcare Inc | 1 | $29 |
| Greer Laboratories, Inc. | 1 | $29 |
| Amgen | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Medtronic | 1 | $17 |
| Organogenesis Inc. | 1 | $17 |
| Acell, Inc. | 1 | $16 |
| Intersect ENT, Inc. | 1 | $15 |
| USWM, LLC | 1 | $15 |
| Xoran Technologies LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$360
- BREZTRI$244
- AIRSUPRA$240
- NUCALA$123
- RHINAER STYLUS$120
- Vivaer RF Stylus$109
- VOQUEZNA$109
- XEOMIN$105
How this compares
$5,579 in reported general payments places this provider in the 90th percentile of 254 otolaryngology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DuleraMometasone/Formoterol | 13 | $4,796 |
| Epinephrine | 15 | $2,874 |
| Omeprazole | 143 | $857 |
| Mupirocin | 70 | $702 |
| Montelukast Sodium | 60 | $511 |
| Esomeprazole Magnesium | 12 | $290 |
| Azithromycin | 69 | $204 |
| Fluticasone Propionate | 16 | $132 |
| Gentamicin Sulfate | 11 | $100 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $78 |
| Triamcinolone Acetonide | 15 | $67 |
| Prednisone | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Enumclaw
- Greg DavisPuyallup$531K
- Ian HumphreysSeattle$43K
- Douglas BackousPuyallup$36K
- Craig MillerSeattle$24K
- Sachin GuptaSeattle$23K
- Sharon CushingSeattle$19K
- Ronald KruegerMukilteo$19K
- Eric WatermanBellevue$15K
- Ryan SternFederal Way$15K
- Todd BerinsteinVancouver$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.